TransMedics to Report Third Quarter 2024 Financial Results on October 28, 2024

Rhea-AI Summary

TransMedics Group, Inc. (Nasdaq: TMDX), a medical technology company focused on transforming organ transplant therapy, has announced that it will release its third quarter 2024 financial results after market close on Monday, October 28, 2024. The company will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on the same day to discuss the results.

Investors can participate in the conference call by dialing (844) 481-2832 for domestic callers or (412) 317-1852 for international callers and requesting to join the TransMedics call. Additionally, a live and archived webcast of the event will be available on the company's investor relations website at https://investors.transmedics.com/.

ANDOVER, Mass., Oct. 15, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the third quarter 2024 after market close on Monday, October 28, 2024. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (844) 481-2832 for domestic callers or (412) 317-1852 for international callers and ask to be joined into the TransMedics call. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-third-quarter-2024-financial-results-on-october-28-2024-302276974.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics (TMDX) release its Q3 2024 financial results?

TransMedics (TMDX) will release its third quarter 2024 financial results after market close on Monday, October 28, 2024.

What time is the TransMedics (TMDX) Q3 2024 earnings conference call?

The TransMedics (TMDX) Q3 2024 earnings conference call is scheduled for 4:30 p.m. ET / 1:30 p.m. PT on Monday, October 28, 2024.

How can investors listen to TransMedics' (TMDX) Q3 2024 earnings call?

Investors can listen to TransMedics' (TMDX) Q3 2024 earnings call by dialing (844) 481-2832 for domestic callers or (412) 317-1852 for international callers, or by accessing the webcast on the company's investor relations website.

Where can I find the webcast for TransMedics' (TMDX) Q3 2024 earnings call?

The webcast for TransMedics' (TMDX) Q3 2024 earnings call will be available on the 'Investors' section of the company's website at https://investors.transmedics.com/.